MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dopamine"

  • 2019 International Congress

    Striatal dopaminergic dysregulation and dystonia-like movements induced by peripheral nerve crush in a transgene DYT1 mouse model

    L. Rauschenberger, A. Stengl, S. Knorr, K. Grundmann-Hauser, J. Volkmann, CW. Ip (Würzburg, Germany)

    Objective: To study changes of the dopaminergic pathway of a transgene DYT1 dystonia mouse model after induction of a dystonic phenotype by peripheral nerve crush.…
  • 2019 International Congress

    Neuropsychiatric manifestations in Parkinson’s disease

    O. Cherkaoui Rhazouani, N. Jalami, M. Chraa, N. Kissani (Marrakech, Morocco)

    Objective: Evaluate the different neuropsychiatric manifestations in Parkinson's disease. Background: Parkinson's disease (PD) is the second most common neurodegenerative pathology after Alzheimer's disease, although PD…
  • 2019 International Congress

    Cerebral differences between dopamine-resistant and dopamine-responsive Parkinson’s tremor

    MF. Dirkx, H. Zach, A. van Nuland, BR. Bloem, I. Toni, RC. Helmich (Nijmegen, Netherlands)

    Objective: To disentangle the cerebral mechanisms underlying dopamine-resistant versus dopamine-responsive tremor in Parkinson’s disease. Background: Parkinson’s rest tremor is related to cerebral activity in both…
  • 2019 International Congress

    Screening of mutations in PARK2 gene and Dopamine levels in Parkinson’s disease (PD) patients in Coimbatore population, India

    B. Vellingiri, D. Venkatesan (Coimbatore, India)

    Objective: The aim of the present study was to perform the mutational screening of PARK2 gene and dopamine level in PD patients of Coimbatore population,…
  • 2019 International Congress

    Combination Antiretroviral therapy (cART)-induced cerebellar and prefrontal cortex disorders: A Study on the impact of Naringenin and Quercetin

    E. Akang, O. Dosumu, A. Fagaroye, I. Usman, A. Oremosu, A. Akanmu (Lagos, Nigeria)

    Objective: This study was designed to investigate the therapeutic potential of selected bioflavonoids on cART-induced neurological disorders. Background: Long term usage of combination antiretroviral therapy…
  • 2018 International Congress

    Management of chronic polyneuropathy associated with levodopa-carbidopa intestinal gel infusion in Parkinson’s disease: Review of the strategies and perspectives

    C. Cransac, J. Dupouy, P. Loubiere, B. Ackett, P. Cintas, C. Brefel Courbon, O. Rascol, F. ory Magne (Toulouse, France)

    Objective: (1) To make an inventory of the current strategies used to treat or prevent the occurrence of chronic polyneuropathy (CPN) in patients with Parkinson’s…
  • 2018 International Congress

    The Effect of Sleep Deprivation on Short-Term Memory and Emotion of Rotenone Treated Zebrafish Model of Parkinson Disease

    Y. Xiong, D. Lv, S. Wei, F. Wang, C. Liu (Suzhou, China)

    Objective: We investigated the long-term consequences of sleep deprivation on short-term memory and emotion using a rotenone treated zebrafish model of Parkinson disease. Background: Parkinson…
  • 2018 International Congress

    Impact of STN-DBS on Medication Reduction

    M. Carmona-Abellán, G. de Ulibarri, J. Guridi, P. Clavero, M. Alegre, R. Luquin-Piudo (Pamplona, Spain)

    Objective: We aim to evaluate the efficacy of subthalamic nucleus deep brain stimulation on reducing medication in Parkinson´s disease patients. Background: Parkinson's disease (PD) is…
  • 2018 International Congress

    Off-painfull state in Parkinson’s disease patients: A redflag of complulsive behavior. Data from a PET-FDG study

    G. Albani, A. Cistaro, P. Fania, S. Margotti, V. Arena, A. Mauro (Verbania, Italy)

    Objective: The aim of this study was to investigate the neural underpinnings of the dopaminergic dysregulation syndrome( DDS ) during the “off-phase”. Background: The DDS…
  • 2018 International Congress

    Striatum of the ouabain-induced pharmacological DYT12 mouse model is affected by structural and metabolic abnormalities

    L. Rauschenberger, Y. Al-Zuraiqi, J. Volkmann, C.W. Ip (Wuerzburg, Germany)

    Objective: To study changes in neuronal morphology and neurotransmitter metabolism in the striatum of a pharmacological DYT12 mouse model after induction of a dystonic phenotype…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 26
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley